Alnylam Pharma (ALNY) Q4 2024 Earnings Report
MX:ALNY Q4 2024 EPS Results
- Actual EPS
- -MXN 12.27
- Consensus EPS
- -MXN 11.18
- Beat/Miss
- Missed by -MXN 1.10
- One Year Ago EPS
- -MXN 20.77
MX:ALNY Q4 2024 Revenue Results
- Actual Revenue
- MXN 11.20B
- Expected Revenue
- MXN 11.00B
- Beat/Miss
- Beat by +MXN 199.40M
- YoY Revenue Growth
- +34.90%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/13/2025
- Time
- Before Open
- Conference Call
- Thursday, February 13, 2025
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
MX:ALNY Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 32.97- | 15.48 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 31.34296.83 | 34.74 | 754.35% (+262.08) | |
| Jul 30, 2026 | 2026 (Q2) | 30.7822.85 | -9.63 | 337.25% (+32.48) | |
| Apr 30, 2026 | 2026 (Q1) | 16.4728.51 | -8.31 | 443.18% (+36.82) | |
| Feb 12, 2026 | 2025 (Q4) | 21.7115.48 | -12.27 | 226.15% (+27.76) | |
| Oct 30, 2025 | 2025 (Q3) | 10.5934.74 | -16.43 | 311.49% (+51.17) | |
| Jul 31, 2025 | 2025 (Q2) | -10.27-9.63 | -2.45 | -292.31% (-7.18) | |
| May 01, 2025 | 2025 (Q1) | -16.81-8.31 | -9.82 | 15.38% (+1.51) | |
| Feb 13, 2025 | 2024 (Q4) | -11.18-12.27 | -20.77 | 40.91% (+8.50) | |
| Oct 31, 2024 | 2024 (Q3) | -17.31-16.43 | 21.71 | -175.65% (-38.14) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
